Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
Stopped early · Phase 2
Conditions studied: Ankylosing Spondylitis
In brief
Primary Objective: * To assess the long term safety of Sarilumab (SAR153191/REGN88) in participants with ankylosing spondylitis (AS) Secondary Objective: * To assess the long term efficacy of Sarilumab (SAR153191/REGN88) in participants with AS
Key facts
- Study ID
- NCT01118728
- Run by
- Sanofi
- People needed
- 223
- Starts
- 2010-06-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2017-06-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participant with AS who participated and completed 12-week treatment in study DRI11073-NCT01061723.
You may not qualify if…
- Adverse event(s) having lead to treatment discontinuation in the DRI11073 study;
- Event or laboratory abnormality observed at the last treatment visit of DRI11073 study that would have adversely affected participation of the participant in this study as per investigator judgment.
- The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.
Where it is running
- Sanofi-Aventis Administrative Office — Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office — Macquarie Park, New South Wales, Australia
- Sanofi-Aventis Administrative Office — Vienna, Austria
- Sanofi-Aventis Administrative Office — Diegem, Belgium
- Sanofi-Aventis Administrative Office — Laval, Canada
- Sanofi-Aventis Administrative Office — Prague, Czechia
- Sanofi-Aventis Administrative Office — Paris, France
- Sanofi-Aventis Administrative Office — Budapest, Hungary
- Sanofi-Aventis Administrative Office — Vilnius, Lithuania
- Sanofi-Aventis Administrative Office — Gouda, Netherlands
- Sanofi-Aventis Administrative Office — Warsaw, Poland
- Sanofi-Aventis Administrative Office — Barcelona, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.